相似文献
1
Angiogenesis in epithelian ovarian cancer.
Mol Pathol. 2002 Dec;55(6):348-59. doi: 10.1136/mp.55.6.348.
2
Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Oncol Rep. 2003 Jan-Feb;10(1):89-95.
3
4
Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Int J Oncol. 2003 May;22(5):961-7.
5
The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
J Pathol. 2003 Jun;200(2):183-94. doi: 10.1002/path.1339.
6
Prognostic role of angiogenesis in colorectal cancer.
Anticancer Res. 2001 Nov-Dec;21(6B):4349-53.
7
Vascular endothelial growth factor expression in non-small cell lung cancer.
Methods Mol Med. 2003;74:357-73. doi: 10.1385/1-59259-323-2:357.
8
The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Clin Cancer Res. 2002 Jun;8(6):1863-70.
9
VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
Ann Hematol. 2002;81 Suppl 2:S66.
10
[Expression of VEGF and tumor angiogenesis in bladder cancer].
Zhonghua Wai Ke Za Zhi. 2000 Jan;38(1):34-6.
引用本文的文献
1
Bacterial Extracellular Vesicles in Oncology: Molecular Mechanisms and Future Clinical Applications.
Cancers (Basel). 2025 May 26;17(11):1774. doi: 10.3390/cancers17111774.
2
The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.
BMC Cancer. 2025 Feb 11;25(1):233. doi: 10.1186/s12885-025-13640-z.
3
Role of Cancer Side Population Stem Cells in Ovarian Cancer Angiogenesis.
Med Princ Pract. 2024;33(5):403-413. doi: 10.1159/000539642. Epub 2024 Jul 26.
4
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities.
Curr Oncol. 2024 Jul 1;31(7):3826-3844. doi: 10.3390/curroncol31070283.
5
Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer.
J Ovarian Res. 2024 Jul 17;17(1):149. doi: 10.1186/s13048-024-01471-8.
6
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
Ther Adv Med Oncol. 2024 Feb 29;16:17588359241233225. doi: 10.1177/17588359241233225. eCollection 2024.
7
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements.
Int J Mol Sci. 2024 Feb 3;25(3):1845. doi: 10.3390/ijms25031845.
8
The long non-coding RNA NEAT1 promotes the progression of human ovarian cancer through targeting miR-214-3p and regulating angiogenesis.
J Ovarian Res. 2023 Nov 20;16(1):219. doi: 10.1186/s13048-023-01309-9.
9
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine.
Front Pharmacol. 2023 Mar 7;14:1147717. doi: 10.3389/fphar.2023.1147717. eCollection 2023.
10
Differential Expression of HIF1A, EPAS1, and VEGF Genes in Benign and Malignant Ovarian Neoplasia.
Cancers (Basel). 2022 Oct 7;14(19):4899. doi: 10.3390/cancers14194899.
本文引用的文献
1
Vascular endothelial growth-factor expression and angiogenesis in nonsmall cell lung carcinomas.
Int J Oncol. 1995 May;6(5):1059-62. doi: 10.3892/ijo.6.5.1059.
2
HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS : I. THE TRANSFER OF RABBIT TUMORS TO ALIEN SPECIES.
J Exp Med. 1941 Mar 31;73(4):461-74. doi: 10.1084/jem.73.4.461.
3
Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis.
Trends Cell Biol. 1997 May;7(5):182-6. doi: 10.1016/S0962-8924(97)01037-4.
4
Angiogenesis as a biomarker and target in cancer chemoprevention.
Lancet Oncol. 2001 Dec;2(12):726-32. doi: 10.1016/S1470-2045(01)00586-1.
5
Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma.
Cancer Lett. 2002 Feb 8;176(1):111-8. doi: 10.1016/s0304-3835(01)00754-6.
6
Identification of an angiogenic mitogen selective for endocrine gland endothelium.
Nature. 2001 Aug 30;412(6850):877-84. doi: 10.1038/35091000.
7
Different features of angiogenesis between ovarian and breast carcinoma.
Cancer Lett. 2001 Sep 20;170(2):161-7. doi: 10.1016/s0304-3835(01)00588-2.
8
A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression.
J Natl Cancer Inst. 2001 May 16;93(10):734-5. doi: 10.1093/jnci/93.10.734.
9
Angiogenesis in cancer and other diseases.
Nature. 2000 Sep 14;407(6801):249-57. doi: 10.1038/35025220.
10
Vascular-specific growth factors and blood vessel formation.
Nature. 2000 Sep 14;407(6801):242-8. doi: 10.1038/35025215.
Zotero 插件